116 related articles for article (PubMed ID: 11808822)
1. Population pharmacodynamic modeling without plasma concentrations of rocuronium in children.
Velázquez-Armenta EY; Nava-Ocampo AA
J Clin Pharmacol; 2002 Jan; 42(1):37-42. PubMed ID: 11808822
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis.
van Miert MM; Eastwood NB; Boyd AH; Parker CJ; Hunter JM
Br J Clin Pharmacol; 1997 Aug; 44(2):139-44. PubMed ID: 9278198
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children.
Woloszczuk-Gebicka B; Wyska E; Grabowski T; Swierczewska A; Sawicka R
Paediatr Anaesth; 2006 Jul; 16(7):761-8. PubMed ID: 16879519
[TBL] [Abstract][Full Text] [Related]
4. Rocuronium pharmacokinetic-pharmacodynamic relationship under stable propofol or isoflurane anesthesia.
Dragne A; Varin F; Plaud B; Donati F
Can J Anaesth; 2002 Apr; 49(4):353-60. PubMed ID: 11927473
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic-pharmacodynamic modeling of rocuronium in case of a decreased number of acetylcholine receptors: a study in myasthenic pigs.
De Haes A; Proost JH; De Baets MH; Stassen MH; Houwertjes MC; Wierda JM
Anesthesiology; 2003 Jan; 98(1):133-42. PubMed ID: 12502989
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamics and pharmacokinetics of rocuronium in intensive care patients.
Sparr HJ; Wierda JM; Proost JH; Keller C; Khuenl-Brady KS
Br J Anaesth; 1997 Mar; 78(3):267-73. PubMed ID: 9135303
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacokinetic-dynamic modelling of rocuronium in infants and children.
Wierda JM; Meretoja OA; Taivainen T; Proost JH
Br J Anaesth; 1997 Jun; 78(6):690-5. PubMed ID: 9215021
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of rocuronium in patients with cirrhosis.
Khalil M; D'Honneur G; Duvaldestin P; Slavov V; De Hys C; Gomeni R
Anesthesiology; 1994 Jun; 80(6):1241-7. PubMed ID: 8010470
[TBL] [Abstract][Full Text] [Related]
9. Influence of real-time Bayesian forecasting of pharmacokinetic parameters on the precision of a rocuronium target-controlled infusion.
Motamed C; Devys JM; Debaene B; Billard V
Eur J Clin Pharmacol; 2012 Jul; 68(7):1025-31. PubMed ID: 22349465
[TBL] [Abstract][Full Text] [Related]
10. Target-controlled infusion of rocuronium in infants, children, and adults: a comparison of the pharmacokinetic and pharmacodynamic relationship.
Saldien V; Vermeyen KM; Wuyts FL
Anesth Analg; 2003 Jul; 97(1):44-9, table of contents. PubMed ID: 12818941
[TBL] [Abstract][Full Text] [Related]
11. [Estimated blood concentration of rocuronium administrated by continuous infusion to maintain an appropriate neuromuscular blockade under propofol anesthesia].
Ito S; Nagata O; Ozaki M
Masui; 2010 Jan; 59(1):82-6. PubMed ID: 20077775
[TBL] [Abstract][Full Text] [Related]
12. Effects of hypothermic cardiopulmonary bypass on the pharmacodynamics and pharmacokinetics of rocuronium.
Smeulers NJ; Wierda JM; van den Broek L; Gallandat Huet RC; Hennis PJ
J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):700-5. PubMed ID: 8664462
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability of intramuscular rocuronium in infants and children.
Reynolds LM; Lau M; Brown R; Luks A; Sharma M; Fisher DM
Anesthesiology; 1997 Nov; 87(5):1096-105. PubMed ID: 9366462
[TBL] [Abstract][Full Text] [Related]
14. The effect of isoflurane versus balanced anesthesia on rocuronium's pharmacokinetics and infusion requirement.
Larijani GE; Gratz I; Afshar M; McDonald PA; Fisher DM
Pharmacotherapy; 1995; 15(1):36-41. PubMed ID: 7739943
[TBL] [Abstract][Full Text] [Related]
15. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK/PD analysis.
Woloszczuk-Gebicka B; Wyska E; Grabowski T
Paediatr Anaesth; 2007 Jul; 17(7):637-46. PubMed ID: 17564645
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic/pharmacodynamic modeling of rocuronium in myasthenic patients is improved by taking into account the number of unbound acetylcholine receptors.
De Haes A; Proost JH; Kuks JB; van den Tol DC; Wierda JM
Anesth Analg; 2002 Sep; 95(3):588-96, table of contents. PubMed ID: 12198043
[TBL] [Abstract][Full Text] [Related]
17. Accelerated recovery and disposition from rocuronium in an end-stage renal failure patient on chronic anticonvulsant therapy with sodium valproate and primidone.
Driessen JJ; Robertson EN; Booij LH; Vree TB
Br J Anaesth; 1998 Mar; 80(3):386-8. PubMed ID: 9623443
[TBL] [Abstract][Full Text] [Related]
18. Interstitial muscle concentrations of rocuronium under steady-state conditions in anaesthetized dogs: actual versus predicted values.
Ezzine S; Varin F
Br J Anaesth; 2005 Jan; 94(1):49-56. PubMed ID: 15542539
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of rocuronium during the three stages of liver transplantation.
Fisher DM; Ramsay MA; Hein HA; Marcel RJ; Sharma M; Ramsay KJ; Miller RD
Anesthesiology; 1997 Jun; 86(6):1306-16. PubMed ID: 9197300
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of rocuronium in children aged 4-11 years.
Vuksanaj D; Fisher DM
Anesthesiology; 1995 May; 82(5):1104-10. PubMed ID: 7741284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
